BridgeMD
Compares treatment options for Glue Embolization
Official title Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome
ClinicalTrials.gov ID: NCT06560294
What this study is testing
What is Micronized purified flavonoid fraction (Daflon ®)?
Micronized purified flavonoid fraction (Daflon ®) is an investigational medicine, given as an once-daily, being studied as a potential treatment for glue embolization.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this study is to compare glue embolization and conservative treatment for pelvic congestion syndrome regarding safety and efficacy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 50, women only
You may be able to join if
- Women aged from 30 to 50 years.
- Complaining from pelvic congestion syndrome.
You likely can't join if
- Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers.
- Patients who are treated with opiates to reduce pelvic pain in the period before the study.
- Patient with history of contrast allergy
- Patient with renal impairment
- Patient has alternative gynecological cause of chronic pelvic pain as pelvic inflammatory disease (PID), endometriosis, fibroid, adenomyosis, ovarian...
- Patient underwent any previous intervention for pelvic congestion syndrome as laparoscopy or surgery.
The study team makes the final eligibility decision.
Where it's taking place
- Tanta, ElGharbia, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 30 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tanta, ElGharbia, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.